Jyothy Labs Ltd is a leading Indian FMCG company known for its strong presence in fabric care, dishwashing, household insecticides, and personal care segments. Founded in 1983 by M.P. Ramachandran, the company owns iconic brands like Ujala (fabric whitener), Exo and Pril (dishwash), and Maxo (insecticides). With over 84% market share in fabric whiteners and a debt-free balance sheet, Jyothy Labs has built a loyal consumer base through value-for-money products and rural penetration. Despite modest recent growth, its high return ratios and consistent dividends make it a compelling name in the small-cap FMCG space. This article provides a data-backed outlook on the Jyothy Labs share price target 2026–2030.
Jyothy Labs Ltd: Company Overview
- Founded: 1983
- Headquarters: Thrissur, Kerala
- Key Segments: Fabric Care (50%+ of revenue), Dishwashing, Household Insecticides, Personal Care
- Market Position: #1 in fabric whiteners; top-3 in liquid dishwash in South India
- Ownership: Promoter-held (62.89%) with strong institutional backing
Jyothy Labs operates with a lean, asset-light model, focusing on brand equity and distribution efficiency rather than capital-intensive manufacturing. Its zero-debt structure and high cash conversion support shareholder returns.
Jyothy Labs Ltd: Key Financial Snapshot
| Metric | Value |
|---|---|
| Current Share Price | ₹249.00 |
| Market Capitalization | ₹9,158.33 Cr |
| No. of Shares Outstanding | 36.72 Cr |
| 52-Week High / Low | ₹423 / ₹244 |
| P/E Ratio (TTM) | 26.24 |
| P/B Ratio | 6.37 |
| EPS (TTM) | ₹9.50 |
| Book Value (TTM) | ₹39.16 |
| ROE | 29.44% |
| ROCE | 39.26% |
| Dividend Yield | 1.40% |
| Face Value | ₹1 |
| Cash | ₹142.35 Cr |
| Total Debt | ₹0 Cr |
| Debt-to-Equity | 0.00 |
| Sales Growth (YoY) | 3.26% |
| Profit Growth (YoY) | 0.35% |
| Promoter Holding | 62.89% |
Jyothy Labs Ltd Share Price Target Forecast (2026–2030)
| Year | Target Price Range (₹) |
|---|---|
| 2026 | ₹265 – ₹295 |
| 2027 | ₹285 – ₹325 |
| 2028 | ₹305 – ₹360 |
| 2029 | ₹325 – ₹400 |
| 2030 | ₹345 – ₹440 |
Jyothy Labs Ltd Share Price Target 2026
| Year | Share Price Target 1 | Share Price Target 2 |
|---|---|---|
| 2026 | ₹265 | ₹295 |
Jyothy Labs reported near-flat profit growth (0.35%) and modest sales growth (3.26%) in FY2025, impacted by intense competition and input cost pressures. However, its ROCE of 39.26% and ROE of 29.44% remain industry-leading. Trading at a P/E of 26.2x—slightly above the FMCG small-cap average—the stock reflects quality premium. A 2026 target of ₹265–₹295 assumes stable margins and continued brand strength.
Jyothy Labs Ltd Share Price Target 2027
| Year | Share Price Target 1 | Share Price Target 2 |
|---|---|---|
| 2027 | ₹285 | ₹325 |
The company’s focus on premium variants (e.g., Ujala Young & Fresh, Pril Gold) and expansion into North India could drive volume recovery. If EPS reaches ₹10.50–₹11.20 by FY27 and P/E holds at 26–28x, the 2027 range of ₹285–₹325 is realistic.
Jyothy Labs Ltd Share Price Target 2028
| Year | Share Price Target 1 | Share Price Target 2 |
|---|---|---|
| 2028 | ₹305 | ₹360 |
By 2028, benefits from rural distribution deepening and new product launches should support top-line momentum. Assuming EPS of ₹11.20–₹12.50 and P/E of 27–28x, the ₹305–₹360 band is justified.
Jyothy Labs Ltd Share Price Target 2029
| Year | Share Price Target 1 | Share Price Target 2 |
|---|---|---|
| 2029 | ₹325 | ₹400 |
Long-term tailwinds include rising disposable income in semi-urban India and category penetration. Risks include competition from HUL, Godrej, and private labels. Using a P/E of 28–30x on projected EPS (~₹11.50–₹13.30), the 2029 target is ₹325–₹400.
Jyothy Labs Ltd Share Price Target 2030
| Year | Share Price Target 1 | Share Price Target 2 |
|---|---|---|
| 2030 | ₹345 | ₹440 |
Over a five-year horizon, Jyothy Labs’ value lies in its irreplaceable brand moat and capital efficiency—not explosive growth. A terminal P/E of 29–31x on FY30 EPS (~₹12–₹14.20) supports the ₹345–₹440 range.
Jyothy Labs Ltd: Shareholding Pattern
| Category | Holding (%) |
|---|---|
| Promoters | 62.89% |
| Domestic Institutional Investors (DII) | 15.14% |
| Foreign Institutional Investors (FII) | 12.77% |
| Public & Retail | 9.20% |
| Others | 0.00% |
High promoter holding ensures strategic continuity, while rising institutional interest reflects confidence in governance.
Jyothy Labs Ltd: Strengths vs Risks
Strengths:
- Zero debt and ₹142 Cr cash—exceptional balance sheet strength
- Industry-leading ROCE (39.26%) and ROE (29.44%)
- Strong brand leadership in niche categories (Ujala, Exo)
- Consistent dividend payer (1.4% yield; ~38% payout ratio)
Risks:
- Modest sales growth (3.26%) due to competitive intensity
- P/B of 6.37x is rich for a small-cap FMCG player
- Limited national presence outside South India
- Vulnerable to raw material (surfactant) price volatility
Investment Suitability
| Factor | Assessment |
|---|---|
| Risk Profile | Moderate |
| Ideal Time Horizon | 3–5+ years |
| Volatility | Moderate (small-cap FMCG) |
| Dividend/Income Potential | Yes (1.4% yield + consistent payouts) |
| Best For | Quality-focused investors seeking branded FMCG exposure |
- Near-flat profit growth (0.35%) in FY25
- Intense competition in dishwashing and fabric care
- Rich valuation (P/B: 6.37x) prompting profit-taking
Final Verdict
Jyothy Labs Ltd combines category leadership, financial prudence, and brand trust. While near-term growth is muted, its capital efficiency and dividend consistency offer defensive appeal. Our Jyothy Labs share price target 2026–2030 (₹265 to ₹440) reflects steady appreciation driven by return ratios—not speculation.
Disclaimer: Price targets are estimates based on publicly available data and sector analysis. They are not investment advice. Consult a SEBI-registered advisor before making decisions.
Sources
- Screener.in – Jyothy Labs Consolidated Page (FY2025 + TTM)
- Finology Ticker – JYOTHYLAB Financial Ratios & Valuation
- Jyothy Labs Investor Presentation (Q2 FY26, Nov 2025)
- BSE India – Annual Report FY2025
- Nielsen India – FMCG Market Share Reports (2025)
